Sorrento Therapeutics Profit Margin 2008-2021 | SRNE
Current and historical gross margin, operating margin and net profit margin for Sorrento Therapeutics (SRNE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Sorrento Therapeutics net profit margin as of June 30, 2021 is -626.43%.
|Sorrento Therapeutics Annual Profit Margins
|Sorrento Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.